AVVH (AVVAA World Health Care Products) Debt-to-Equity: -0.12 (As of May. 2007)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AVVAA World Health Care Products Debt-to-Equity?

AVVAA World Health Care Products AVVH -12.28% Debt-to-Equity is -0.12 as of May. 2007.

AVVAA World Health Care Products's Short-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2007 was $1.70 Mil. AVVAA World Health Care Products's Long-Term Debt & Capital Lease Obligation for the quarter that ended in May. 2007 was $0.00 Mil. AVVAA World Health Care Products's Total Stockholders Equity for the quarter that ended in May. 2007 was $-13.92 Mil. AVVAA World Health Care Products's debt to equity for the quarter that ended in May. 2007 was -0.12.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AVVAA World Health Care Products's Debt-to-Equity or its related term are showing as below:

AVVH's Debt-to-Equity is not ranked *
in the Banks industry.
Industry Median: 0.58
* Ranked among companies with meaningful Debt-to-Equity only.

AVVAA World Health Care Products  (OTCPK:AVVH) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

AVVAA World Health Care Products Debt-to-Equity Related Terms

AVVAA World Health Care Products Debt-to-Equity Historical Data

* Premium members only.

The historical data trend for AVVAA World Health Care Products's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AVVAA World Health Care Products Debt-to-Equity Chart

AVVAA World Health Care Products Annual Data
Trend May00 May01 May02 May03 May04 May05 May06 May07
Debt-to-Equity
Get a 7-Day Free Trial 0.00 -0.61 -0.09 -0.09 -0.12

AVVAA World Health Care Products Semi-Annual Data
May00 May01 May02 May03 May04 May05 May06 May07
Debt-to-Equity Get a 7-Day Free Trial 0.00 -0.61 -0.09 -0.09 -0.12

AVVH vs PAPL, AAMCF, LFLS: Debt-to-Equity Comparison

For the Mortgage Finance subindustry, AVVAA World Health Care Products's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AVVAA World Health Care Products Debt-to-Equity vs Banks Industry

For the Banks industry and Financial Services sector, AVVAA World Health Care Products's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AVVAA World Health Care Products's Debt-to-Equity falls into.


AVVAA World Health Care Products Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AVVAA World Health Care Products's Debt to Equity Ratio for the fiscal year that ended in May. 2007 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.696 + 0) / -13.915
=-0.12

AVVAA World Health Care Products's Debt to Equity Ratio for the quarter that ended in May. 2007 is calculated as

Debt to Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(1.696 + 0) / -13.915
=-0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Debt-to-Equity →
What does a Debt-to-Equity of -0.12 mean?
AVVAA World Health Care Products (AVVH) has a Debt-to-Equity of -0.12 as of May. 2007. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on AVVAA World Health Care Products and its competitors.
Is AVVAA World Health Care Products' Debt-to-Equity too high?
AVVAA World Health Care Products' current Debt-to-Equity is -0.12.
How does AVVAA World Health Care Products' Debt-to-Equity compare to PAPL and AAMCF?
AVVAA World Health Care Products' Debt-to-Equity of -0.12 can be compared against companies in the Banks industry. The industry median Debt-to-Equity is 0.58. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Banks company?
The median Debt-to-Equity among Banks companies is 0.58, based on 1,421 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on AVVAA World Health Care Products and its competitors. For the Banks industry, the median Debt-to-Equity is 0.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AVVAA World Health Care Products's current Debt-to-Equity is -0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AVVAA World Health Care Products stock overvalued right now?
AVVAA World Health Care Products (AVVH) has a current Debt-to-Equity of -0.12. The current Debt-to-Equity is -0.12. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For AVVAA World Health Care Products (AVVH), the current Debt-to-Equity is -0.12 as of May. 2007. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AVVAA World Health Care Products Business Description

Address 1001 West Loop South, Suite 803, Houston, TX, USA, 77027
AVVAA World Health Care Products Inc is a capital financing company for real estate borrowings.